Mark McKechnie - 18 Nov 2021 Form 4 Insider Report for ACM Research, Inc. (ACMR)

Role
Chief Financial Officer, Executive Vice President and Treasurer
Signature
/s/ Mark L. Johnson, Attorney-in-Fact for Mark McKechnie
Issuer symbol
ACMR
Transactions as of
18 Nov 2021
Net transactions value
-$401,016
Form type
4
Filing time
22 Nov 2021, 16:00:37 UTC
Previous filing
20 Aug 2021
Next filing
11 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACMR Class A Common Stock Options Exercise $69,250 +5,000 $13.85 5,000 18 Nov 2021 Direct F1
transaction ACMR Class A Common Stock Sale $38,745 -421 -8.4% $92.03* 4,579 18 Nov 2021 Direct F2, F3
transaction ACMR Class A Common Stock Sale $272,441 -2,932 -64% $92.92* 1,647 18 Nov 2021 Direct F2, F4
transaction ACMR Class A Common Stock Sale $56,967 -607 -37% $93.85* 1,040 18 Nov 2021 Direct F2, F5
transaction ACMR Class A Common Stock Sale $36,027 -374 -36% $96.33* 666 18 Nov 2021 Direct F2, F6
transaction ACMR Class A Common Stock Sale $19,512 -200 -30% $97.56* 466 18 Nov 2021 Direct F2
transaction ACMR Class A Common Stock Sale $29,874 -300 -64% $99.58* 166 18 Nov 2021 Direct F2
transaction ACMR Class A Common Stock Sale $16,700 -166 -100% $100.60* 0 18 Nov 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACMR Stock Option Options Exercise $0 -5,000 -33% $0.000000 9,972 18 Nov 2021 Class A Common Stock 5,000 $13.85 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 18, 2021, the reporting person exercised a previously issued stock option to purchase 5,000 shares of Class A Common Stock of the Issuer.
F2 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.29 to $92.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5) and (6) to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.42 to $93.20, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $93.98, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.32 to $96.37, inclusive.
F7 The option vested and became exercisable as to 10,000 shares on August 1, 2019, and the remaining 30,000 shares vest and became or become exercisable in equal monthly installments over the following 36 months, subject to continued service through each vesting date.

Remarks:

Chief Financial Officer, Executive Vice President and Treasurer